These results align with the outcomes of previous bioinformatics analysis, RILPL2 expression was low in tumor cells in NSCLC, low RILPL2 expression demonstrated a substantial association with advanced disease stage and poor prognosis, and RILPL2 expression exhibited a pronounced positive correlation with CD4 + and CD8 + T cell infiltration. Here, RILPL2 is linked to non-small cell lung carcinoma.